A

Anthem Biosciences Ltd
NSE:ANTHEM

Watchlist Manager
Anthem Biosciences Ltd
NSE:ANTHEM
Watchlist
Price: 639.75 INR -1.8% Market Closed
Market Cap: 359.3B INR

Intrinsic Value

The intrinsic value of one ANTHEM stock under the Base Case scenario is 356.08 INR. Compared to the current market price of 639.75 INR, Anthem Biosciences Ltd is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ANTHEM Intrinsic Value
356.08 INR
Overvaluation 44%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Anthem Biosciences Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ANTHEM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ANTHEM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Anthem Biosciences Ltd.

Explain Valuation
Compare ANTHEM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ANTHEM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Anthem Biosciences Ltd

Balance Sheet Decomposition
Anthem Biosciences Ltd

Current Assets 17.4B
Cash & Short-Term Investments 7.3B
Receivables 4.6B
Other Current Assets 5.4B
Non-Current Assets 10.7B
Long-Term Investments 234.3m
PP&E 10B
Intangibles 38.7m
Other Non-Current Assets 454.5m
Current Liabilities 3.3B
Accounts Payable 1.1B
Accrued Liabilities 196.6m
Other Current Liabilities 2B
Non-Current Liabilities 714.9m
Long-Term Debt 498.8m
Other Non-Current Liabilities 216m
Efficiency

Free Cash Flow Analysis
Anthem Biosciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Anthem Biosciences Ltd

Revenue
18.4B INR
Cost of Revenue
-7.9B INR
Gross Profit
10.5B INR
Operating Expenses
-4.7B INR
Operating Income
5.8B INR
Other Expenses
-1.3B INR
Net Income
4.5B INR
Fundamental Scores

ANTHEM Profitability Score
Profitability Due Diligence

Anthem Biosciences Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Exceptional Operating Margin
Positive ROIC
Exceptional Gross Margin
Strong 3Y Average Operating Margin
60/100
Profitability
Score

Anthem Biosciences Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

ANTHEM Solvency Score
Solvency Due Diligence

Anthem Biosciences Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
86/100
Solvency
Score

Anthem Biosciences Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANTHEM Price Targets Summary
Anthem Biosciences Ltd

Wall Street analysts forecast ANTHEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANTHEM is 784.38 INR with a low forecast of 747.4 INR and a high forecast of 837.9 INR.

Lowest
Price Target
747.4 INR
17% Upside
Average
Price Target
784.38 INR
23% Upside
Highest
Price Target
837.9 INR
31% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Anthem Biosciences Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ANTHEM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ANTHEM stock?

The intrinsic value of one ANTHEM stock under the Base Case scenario is 356.08 INR.

Is ANTHEM stock undervalued or overvalued?

Compared to the current market price of 639.75 INR, Anthem Biosciences Ltd is Overvalued by 44%.

Back to Top